Expression of basic fibroblast growth factor, its receptors and syndecans in bladder cancer

International Journal of Immunopathology and Pharmacology

Volumn 22, Issue 3, 2009, Pages 627-638

  Marzioni, Daniela ^a   Lorenzi, T ^a   Mazzucchelli, R ^a   Capparuccia, L ^a   Morroni, M ^a   Fiorini, R ^a   Bracalenti, C ^b   Catalano, A ^a   David, G ^c   Castellucci, M ^a   Muzzonigro, G ^a   Montironi, R ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b General Hospital   (Italy)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

bFGF; Bladder; FGFRs; Immunohistochemistry; RT PCR; Syndecans; Urothelial carcinoma; Western blotting

Indexed keywords

FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR 2; MESSENGER RNA; SYNDECAN; SYNDECAN 1; SYNDECAN 2; SYNDECAN 3; SYNDECAN 4;

ARTICLE; BLADDER CANCER; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UROTHELIUM; WESTERN BLOTTING;

AGED; BLOTTING, WESTERN; CARCINOMA; CYSTECTOMY; FEMALE; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SYNDECAN-1; SYNDECAN-2; SYNDECAN-3; SYNDECAN-4; SYNDECANS; UP-REGULATION; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 70350551947     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200902200308     Document Type: Article

References (34)

1. Lopez-Beltran A, Sauter G, Gasser T, Hartmann A, Schmitz-Dräger BJ, Helpap B et al. Infiltrating urothelial carcinoma. In: WHO Classification of Tumours. Pathology & Genetics. Tumours of the Urinary System and Male Genital Organs, Eble JN, Sauter G, Epstein I and Sesterhenn IA (eds). IARCPress: Lyon, 2004; 93-109.
2. Black PC, Agarwal PK, Dinney CP. Targeted therapies in bladder cancer - an update. Urol Oncol 2007; 25:433-438 (Pubitemid 47362765)
3. Cotton LM, O'Bryan MK, Hinton BT. Cellular signaling by fibroblast growth factors (FGFs) and their receptors (FGFRs) in male reproduction. Endocrine Rev 2008; 29:193-216.
4. Eswarakumar VP, Lax I, Schlessinger J. Cellular signaling by fibroblast growth factor receptors. Cytochine Growth Factor Rev 2005; 16:139-149 (Pubitemid 40616112)
5. Beauvais DM, Rapraeger AC. Syndecan-1-mediated cell spreading requires signaling by alphavbeta3 integrins in human breast carcinoma cells. Exp Cell Res 2003; 286:219-232
6. Mundhenke C, Meyer K, Drew S, Friedl A. Heparan sulfate proteoglycans as regulators of fibroblast growth factor-2 receptor binding in breast carcinomas. Am J Pathol 2002; 160:185-194 (Pubitemid 34052279)
7. Mihalich A, Reina M, Mangioni S Ponti E, Alberti L, Viganò P et al. Different basic fibroblast growth factor and fibroblast growth factor-antisense expression in eutopic endometrial stromal cells derived from women with and without endometriosis. J Clin Endocrinol Metab 2003; 88:2853-2859 (Pubitemid 36724467)
8. Lopez-Beltran A, Alvarez-Kindelan J, Luque RJ, et al. Loss of heterozygosity at 9q32-33 (DBC1 locus) in primary non-invasive papillary urothelial neoplasm of low malignant potential and low-grade urothelial carcinoma of the bladder and their associated normal urothelium. J Pathol 2008; 215:263-272 (Pubitemid 351956707)
9. Munro NP, Knowles MA. Fibroblast growth factors and their receptors in transitional cell carcinoma. J Urol 2003; 169:675-682 (Pubitemid 36133021)
10. Alexander CM, Reichsman F, Hinkes MT, Lincecum J, Becker KA, Cumberledge S et al. Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice. Nat Genet 2000; 25:329-332 (Pubitemid 30437323)
11. Fears CY, Woods A. The role of syndecans in disease and wound healing. Matrix Biol 2006; 25:443-456 (Pubitemid 44512121)
12. Couchman JR. Syndecans: proteoglycan regulators of cell-surface microdomains? Nat Rev Mol Cell Biol 2003; 4:926-937
13. Fears CY, Gladson CL, Woods A. Syndecan-2 is expressed in the microvasculature of gliomas and regulates angiogenic processes in microvascular endothelial cells. J Biol Chem 2006; 28:14533-14536 (Pubitemid 43855155)
14. Contreras HR, Fabre M, Granés F, Casaroli-Marano R, Rocamora N, Herreros AG et al. Syndecan-2 expression in colorectal cancer-derived HT-29 M6 epithelial cells induces a migratory phenotype. Biochem Biophys Res Commun 2001; 286:742-751 (Pubitemid 32912950)
15. Greene DK, Tumova S, Couchman JR, Woods A. Syndecan-4 associates with alpha-actinin. J Biol Chem 2003; 278:7617-7623
16. Longley RL, Woods A, Fleetwood A, Cowling GJ, Gallagher JT, Couchman JR. Control of morphology, cytoskeleton and migration by syndecan-4. J Cell Sci 1999; 112:3421-3431
17. Mennerich D, Vogel A, Klaman I, Dahl E, Lichtner RB, Rosenthal A et al. Shift of syndecan-1 expression from epithelial to stromal cells during progression of solid tumours. Eur J Cancer 2004; 40:1373-1382 (Pubitemid 38737024)
18. Roskams T, De Vos R, David G, Van Damme B, Desmet V. Heparan sulphate proteoglycan expression in human primary liver tumours. J Pathol 1998; 185:290-297 (Pubitemid 28320051)
19. Sobin LH and Wittekind C. TNM classification of malignant tumours. Sixth Edition, Sobin LH and Wittekind C (eds). Wiley-Liss: New York, 2002.
20. Anteby EY, Natanson-Yaron S, Hamani Y, Sciaki Y, Goldman-Wohl D, Greenfield C et al. Fibroblast growth factor-10 and fibroblast growth factor receptors 1-4: expression and peptide localization in human deciduas and placenta. Eur J Obstet Gynecol Reprod Biol 2005; 119:27-35. (Pubitemid 40289094)
21. Crescimanno C, Marzioni D, Paradinas FJ, Schrurs B, Mühlhauser J, Todros T et al. Expression pattern alterations of syndecans and glypican-1 in normal and pathological trophoblast. J Pathol 1999; 189:600-608
22. Hjelm Cluff A, Malmström A, Tigåker B, David G, Ekman-Ordeberg G. Normal labor associated with changes in uterine heparan sulfate proteoglycan expression and localization. Acta Obstet Gynecol Scand 2005; 84:217-224 (Pubitemid 40333100)
23. Muehlhauser J, Marzioni D, Morroni M, Vuckovic M, Crescimanno C, Castellucci M. Codistribution of basic fibroblast growth factor and heparan sulfate proteoglycan in the growth zones of the human placenta. Cell Tissue Res 1996; 285:101-107 (Pubitemid 26257630)
24. Chen CH, Jiang W, Via DP, Luo S, Li TR, Lee YT et al. Oxidized low-density lipoproteins inhibit endothelial cell proliferation by suppressing basic fibroblast growth factor expression. Circulation 2000; 101:171-177 (Pubitemid 30044257)
25. Li AW, Murphy PR. Expression of alternatively spliced FGF-2 antisense RNA transcripts in the central nervous system: regulation of FGF-2 mRNA translation. Mol Cell Endocrinol 2000; 162: 69-78.
26. Morrison RS, Yamaguchi F, Saya H, Bruner JM, Yahanda AM, Donehower LA et al. Basic fibroblast growth factor and fibroblast growth factor receptor I are implicated in the growth of human astrocytomas. J Neurooncol 1994; 18:207-216 (Pubitemid 24209422)
27. Yamaguchi F, Saya H, Bruner JM, Morrison RS. Differential expression of two fibroblast growth factor-receptor genes is associated with malignant progression in human astrocytomas. Proc Natl Acad Sci USA 1994; 91:484-488 (Pubitemid 24041426)
28. Myoken Y, Myoken Y, Okamoto T, Kan M, McKeehan WL, Sato JD, et al. Expression of fibroblast growth factor-1 (FGF-1), FGF-2 and FGF receptor-1 in a human salivary-gland adenocarcinoma cell line: evidence of growth. Int J Cancer 1996; 65:650-657 (Pubitemid 26092294)
29. Berger W, Setinek U, Mohr T, Kindas-Mügge I, Vetterlein M, Dekan G et al. Evidence for a role of FGF-2 and FGF receptors in the proliferation of non-small cell lung cancer cells. Int J Cancer 1999; 83: 415-423 (Pubitemid 29455767)
30. Volm M, Koomägi R, Mattern J, Stammler G. Prognostic value of basic fibroblast growth factor and its receptor (FGFR-1) in patients with non-small cell lung carcinomas. Eur J Cancer 1997; 33:691-693 (Pubitemid 27223759)
31. Bernard-Pierrot I, Ricol D, Cassidy A, et al. Inhibition of human bladder tumour cell growth by fibroblast growth factor receptor 2b is independent of its kinase activity. Involvement of the carboxyterminal region of the receptor. Oncogene 2004; 23:9201-9211
32. Hart KC, Robertson SC, Kanemitsu MY, Meyer AN, Tynan JA, Donoghue DJ. Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4. Oncogene 2000; 19:3309-3320
33. Soler R, Bruschini H, Martins JR, et al. Urinary glycosaminoglycans as biomarker for urothelial injury: is it possible to discriminate damage from recovery? Urology 2008; 72:937-942
34. Lories V, Cassiman JJ, Van den Berghe H, David G. Multiple distinct membrane heparan sulfate proteoglycans in human lung fibroblasts. J Biol Chem 1989; 264:7009-7016 (Pubitemid 19114819)